Research theme for competitive and other funds (2):
2024 - 2027 Association of TRIM27 with type 1 interferon activation in systemic lupus erythematosus
2019 - 2022 M2マクロファージを標的としたループス腎炎新規治療法の開発
Papers (25):
Natsuki Sakurai, Ryusuke Yoshimi, Nobuyuki Yajima, Chiharu Hidekawa, Yosuke Kunishita, Daiga Kishimoto, Yumiko Kawahara Sugiyama, Noriko Kojitani, Naoki Suzuki, Yuji Yoshioka, et al. Characteristic features of late-onset systemic lupus erythematosus: An observational study of data from the Lupus Registry of Nationwide Institutions. Lupus. 2024. 9612033241281507-9612033241281507
Ryusuke Yoshimi, Nobuyuki Yajima, Chiharu Hidekawa, Natsuki Sakurai, Nao Oguro, Kenta Shidahara, Keigo Hayashi, Takanori Ichikawa, Dai Kishida, Yoshia Miyawaki, et al. Effect of Shared Decision-Making on Trust in Physicians in the Management of Systemic Lupus Erythematosus: The Trust Measurement for Physicians and Patients With Systemic Lupus Erythematosus Prospective Cohort Study. Arthritis Care & Research. 2024. 76. 12. 1597-1605
Ryusuke Yoshimi, Nobuyuki Yajima, Chiharu Hidekawa, Natsuki Sakurai, Nao Oguro, Kenta Shidahara, Keigo Hayashi, Takanori Ichikawa, Dai Kishida, Yoshia Miyawaki, et al. Effect of shared decision-making on trust in physicians in the management of systemic lupus erythematosus: The TRUMP2-SLE prospective cohort study. 2024
MicroRNA-27a can contribute to interferon signatures in systemic lupus erythematosus via the suppression of tripartite motif-containing protein 27.
(American College of Rheumatology Annual Scientific Meeting, Atlanta 2020)